
H. Lundbeck
nasdaq copenhagen
H. Lundbeck A/S (HLUNBxcse) is a Danish pharmaceutical company headquartered in Valby, Copenhagen. The company specializes in the research, development, production, and marketing of treatments for brain diseases, including depression, schizophrenia, Alzheimer's disease, epilepsy, and Parkinson's disease. Key products include Abilify Maintena, Brintellix/Trintellix, and Rexulti. Lundbeck is a constituent of the OMX Copenhagen 25 (C25) index on Nasdaq Copenhagen. The company is a global leader in neuroscience pharmaceuticals and a critical contributor to advancing treatments for psychiatric and neurological disorders.
Start trading
H. lundbeck now
At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.
.png?width=2000&height=1471&name=Update%20I2M%20Telefoon%20(1).png)